Business & Regulation

Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty.

We interview Mary Lavin, President of Sartorius North America, about her career.

Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.

Advanz Pharma is fined for substantially hiking the price of a generic drug.

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

The EMA releases its annual report highlighting its achievements throughout 2020.

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

How can pharma make the most of digital technologies?

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.